Clinical Trials Directory

Trials / Completed

CompletedNCT02738424

Reproductibility of Lumbar Spine ADC Based on Different Post-processing Softwares

Status
Completed
Phase
Study type
Observational
Enrollment
98 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lumbar spine bone marrow is well explored in Magnetic Resonance Imaging (MRI) but some bone marrow diseases are hard to analyze with this method. Furthermore, there is heterogeneity in normal bone marrow, called apparent diffusion coefficient (ADC). Histological and technical factors appear to be the cause, but the possible influence of the employed post-processing software has never yet been evaluated. The purpose of this study is to determine if there is variability in lumbar bone ADC related to the post-processing software.

Detailed description

Lumbar spine bone marrow is well explored in MRI. Some bone marrow diseases are hard to analyze in conventional MRI, and diffusion-weighted imaging (DWI) could be an additional diagnostic feature. However, according to the literature, there is heterogeneity in normal bone marrow of the quantitative parameter that it provides, called apparent diffusion coefficient (ADC). Histological and technical factors appear to be the cause, but the possible influence of the employed post-processing software has never yet been evaluated. The purpose of this study is to determine if there is variability in lumbar bone ADC related to the post-processing software.

Conditions

Interventions

TypeNameDescription
OTHERCalculate the ADC scoresThe MRI will be performed on the two groups of patients in the usual care. The intervention will be based on the ADC scores calculation. The scores will be obtained with three types of post-processing softwares : Siemens, PACS Carestream, Osirix.

Timeline

Start date
2015-04-01
Primary completion
2015-11-16
Completion
2015-11-16
First posted
2016-04-14
Last updated
2023-07-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02738424. Inclusion in this directory is not an endorsement.